Ideggyogyaszati szemleHumansNeuromyelitis OpticaHungaryRituximabPractice Guidelines as Topic
[Neuromyelitis optica spectrum disorder: new international recommendations and emerging therapeutic options; current status of domestic practice in diagnostics and therapeutic strategies].
Cecília Rajda
Published: 202510.18071/isz.78.0295
Abstract
Neuromyelitis optica spectrum disorder is a rare neuroimmunological disease associated with unpredictable deterioration. Even the first signs of the disease can be severe enough to lead to permanent neurological impairment, such as loss of vision or…
Preview only. Read the full abstract at the source